Acuta Capital Partners’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-21,281	Closed	-$18.1M	–	49
2020 Q2	$18.1M	Buy	21,281 +1,593	+8%	+$1.35M	5.22%	3
2020 Q1	$7.04M	Buy	+19,688	New	+$7.04M	3.41%	12